Skip to main content
Clinical Trials/JPRN-UMIN000020316
JPRN-UMIN000020316
Completed
未知

The COMparison of satisfaction between patient-led and physician-led titration groups Measured by QOL and self-efficacy scores In Japanese T2D patients study - The COMparison of satisfaction between patient-led and physician-led titration groups Measured by QOL and self-efficacy scores In Japanese T2D patients study (The COMMIT-patient study)

Japan society for Patient Reported Outcome0 sites250 target enrollmentDecember 22, 2015
ConditionsType 2 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
Japan society for Patient Reported Outcome
Enrollment
250
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 22, 2015
End Date
December 12, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japan society for Patient Reported Outcome

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who fall into any of the following criteria are excluded from participating in the study. 1\. Patients with dementia or possibly with dementia, or with psychological illness 2\. Unable to make judgement for themselves, or incapable of reading and writing 3\. Need a proxy's consent to join the study 4\. With visual impairment which interferes with self\-injection 5\. Have an experience of using GLP\-1 or insulin in the past 6\. Currently on systemic steroid, beta\-blocker, monoamine oxidase, etc., that may have an influence on glycemic control 7\. If insulin is contradicted to use, or needs to be carefully used 8\. Have an experience of myocardial infarction, angina, stroke, or cerebral infarction within 6 months before the baseline 9\. With liver failure (ALT is doubled or higher than that of the upper limit in healthy individuals) 10\. With renal impairment (SCr is 125 mumol/L or higher (1\.4 mg/dL or higher) among men, and is 110 mumol/L or higher (1\.3 mg/dL or higher) among women 11\. Possibly pregnant or pregnant, or plant to be pregnant during the study period 12\. Currently have malignancy, or had it in the past 13\. Any condition that physicians think to be inappropriate to join the study

Outcomes

Primary Outcomes

Not specified

Similar Trials